Deep Dive: Disruptive Technologies Archives -

Cell and gene therapies could prove disruptive in terms of the life-changing benefits they could bring to people

Will cell and gene therapies disrupt reimbursement?

https://pharmaphorum.com/r-d/cell-gene-therapy-reimbursement/

Once the stuff of science fiction, an emerging category of medicine is set to be increasingly influential in

Defining the digital therapeutics opportunity

https://pharmaphorum.com/digital/digital-therapeutics-health-evaluation-dta/

Data disruption and applying ‘enabled intelligence’ to convert the promise shown in clinical trials into real-world success. For

Company profile: Evidera

https://pharmaphorum.com/digital/evidera-real-world-clinical-trials-data/

Heads of innovation, communication and digital strategy in pharma reflected at Frontiers Health 2018 on the implications of

What future for pharma in a digital world?

https://pharmaphorum.com/digital/pharma-future-digital-world/

Syneos Health tracks the future paths for healthcare technology to identify what will be truly disruptive for the

Pharma in the age of acceleration

https://pharmaphorum.com/digital/syneos-health-pharma-age-acceleration-digital/

Evidera surveys the adoption of machine learning by the pharmaceutical industry and looks at how it can increase

Opening doors in pharmaceutical development

https://pharmaphorum.com/r-d/evidera-machine-learning-pharmaceutical-development/

Digital therapeutics are adding new elements to the medical world, but their place in the pharmaceutical sector is

Expanding the definition of medicine

https://pharmaphorum.com/digital/digital-therapeutics-definition-dta/

As technology and traditional healthcare converge, some trends in cutting-edge digital health innovation are emerging. Andrew Thompson, CEO

The age of digital medicine is here

https://pharmaphorum.com/digital/age-digital-medicine-health-pharma/

Deep Dive: Disruptive Technologies